CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-18 | MARIANI PETER J Chief Financial Officer | Grant or award | +1,900 | 6,900 | ||
| 2020-12-18 | Friedman Mark Louis VP,Regulatory & Quality | Grant or award | +375 | 8,989 | ||
| 2020-12-15 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise | +15,000 | $4.81 | $72K | 66,056 |
| 2020-12-15 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Shares withheld for taxes | −4,373 | $16.50 | $72K | 61,683 |
| 2020-12-15 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise · Employee Stock Option (right to buy) | −15,000 | 0 | ||
| 2020-12-03 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise | +625 | $4.81 | $3K | 5,427 |
| 2020-12-03 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise | +3,187 | $3.67 | $12K | 8,614 |
| 2020-12-03 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise · Employee Stock Option (right to buy) | −625 | $4.81 | $3K | 0 |
| 2020-12-03 | Friedman Mark Louis VP,Regulatory & Quality | Option exercise · Employee Stock Options (right to buy) | −3,187 | $3.67 | $12K | 0 |
| 2020-11-09 | Donovan Michael Patrick VP Operations | Sale | −17,617 | $15.00 | $264K | 26,029 |
| 2020-11-09 | Zaderej Karen L. CEO | Sale | −14,000 | $14.53 | $203K | 644,869 |
| 2020-11-04 | Gold Mark Stephen Director | Gift | −15,596 | 296,266 | ||
| 2020-10-30 | MARIANI PETER J Chief Financial Officer | Option exercise | +60,000 | $5.04 | $302K | 80,683 |
| 2020-10-30 | MARIANI PETER J Chief Financial Officer | Sale | −60,000 | $12.41 | $745K | 20,683 |
| 2020-10-30 | MARIANI PETER J Chief Financial Officer | Sale | −1,084 | $12.41 | $13K | 19,599 |
| 2020-10-30 | MARIANI PETER J Chief Financial Officer | Sale | −12,854 | $12.41 | $160K | 6,745 |
| 2020-10-30 | MARIANI PETER J Chief Financial Officer | Sale | −1,745 | $12.41 | $22K | 5,000 |
| 2020-10-30 | MARIANI PETER J Chief Financial Officer | Option exercise · Employee Stock Options (Right to Purchase) | −60,000 | 145,000 | ||
| 2020-09-30 | THOMAS PAUL Director | Grant or award · Stock Option (right to purchase) | +45,910 | 45,910 | ||
| 2020-09-15 | Freitag Gregory Gene Director | Option exercise | +13,046 | $3.67 | $48K | 244,530 |
Page 41 of 69 · 1,376 trades